Skip to main content
. 2013 Mar 7;5(3):725–749. doi: 10.3390/nu5030725

Figure 6.

Figure 6

MSA activates caspase- 3 via caspases -8 and -9 in a subset of melanoma cells. (a) MSA treatment (15 μM) activates caspase-3 in SK-Mel 28 melanoma cells, but not in Yusac2 cells, n = 3 for each data point. (b) Both caspase-8 and -9 inhibitors block activation of caspase-3 in HTB66 cells treated for 24 h with 15 μM MSA, n = 3 for each data point. (c) MSA decreases full-length Bid in melanoma cells. Bid levels are restored by both caspase-8 and -9 inhibitors. Results are representative of 2 separate experiments.